Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-035425

Options or other derivatives

  • Director acquired 11,029 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
YOUNG KEVIN Director 2020-06-08 Grant or award · Stock Option (Right to Buy) +11,029 11,029 D
Loading xslF345X03/doc4.xml…